BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23029457)

  • 1. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
    Rosario R; Araki H; Print CG; Shelling AN
    PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
    Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
    PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
    Cheng JC; Klausen C; Leung PC
    PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.
    Rosario R; Cohen PA; Shelling AN
    Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
    Rosario R; Blenkiron C; Shelling AN
    Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
    Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
    Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
    Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA
    PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
    Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
    PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression.
    Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN
    Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptor profiling of ovarian granulosa cell tumors.
    Alexiadis M; Eriksson N; Jamieson S; Davis M; Drummond AE; Chu S; Clyne CD; Muscat GE; Fuller PJ
    Horm Cancer; 2011 Jun; 2(3):157-69. PubMed ID: 21761343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
    Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
    Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse forkhead L2 maintains repression of FSH-dependent genes in the granulosa cell.
    Kuo FT; Fan K; Bentsi-Barnes I; Barlow GM; Pisarska MD
    Reproduction; 2012 Oct; 144(4):485-94. PubMed ID: 22847492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO1 mitigates the SMAD3/FOXL2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
    Schrader KA; Gorbatcheva B; Senz J; Heravi-Moussavi A; Melnyk N; Salamanca C; Maines-Bandiera S; Cooke SL; Leung P; Brenton JD; Gilks CB; Monahan J; Huntsman DG
    PLoS One; 2009 Nov; 4(11):e7988. PubMed ID: 19956657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
    Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
    Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
    Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
    Kim MS; Hur SY; Yoo NJ; Lee SH
    J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
    Leung DTH; Fuller PJ; Chu S
    Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.